UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Prediction of the Optimal Dosing Regimen Using a Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer Immunotherapy

Clinical cancer research, 2018-07, Vol.24 (14), p.3325-3333

2018

Volltextzugriff (PDF)

Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment

PloS one, 2009-09, Vol.4 (9), p.e7226-e7226

2009

Volltextzugriff (PDF)

Tumor-Specific Bacteriophages Induce Tumor Destruction through Activation of Tumor-Associated Macrophages

The Journal of immunology (1950), 2009-03, Vol.182 (5), p.3105-3111

2009

Volltextzugriff (PDF)

Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma

Radiotherapy and oncology, 2005-10, Vol.77 (1), p.88-95

2005

Volltextzugriff (PDF)

Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma

Acta oncologica, 2006, Vol.45 (4), p.493-497

2006

Volltextzugriff (PDF)

Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells

Oncogene, 2000-10, Vol.19 (45), p.5123-5133

2000

Volltextzugriff (PDF)

A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma

Acta oncologica, 2006, Vol.45 (7), p.870-875

2006

Volltextzugriff (PDF)

Modular software architecture for flexible reservation mechanisms on heterogeneous resources

Journal of systems architecture, 2011-04, Vol.57 (4), p.366-382

2011

Volltextzugriff (PDF)

HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice

Cancer Immunology, Immunotherapy, 2009-05, Vol.58 (5), p.653-664

2009

Volltextzugriff (PDF)

Distribution of Foxp3-, CD4- and CD8-positive lymphocytic cells in benign and malignant prostate tissue

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2010-05, Vol.118 (5), p.360-365

2010

Volltextzugriff (PDF)

Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine

The Prostate, 2005-02, Vol.62 (3), p.217-223

2005

Volltextzugriff (PDF)

Phase 1 study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody obinutuzumab (GA101) in B-cell lymphoma patients

Blood, 2012-05, Vol.119 (22), p.5126-5132

2012

Volltextzugriff (PDF)

Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors

Cancer immunology research, 2015-12, Vol.3 (12), p.1344-1355

2015

Volltextzugriff (PDF)

Interference of Macrophage Migration Inhibitory Factor Expression in a Mouse Melanoma Inhibits Tumor Establishment by Up-Regulating Thrombospondin-1

Molecular cancer research, 2007-12, Vol.5 (12), p.1225-1231

2007

Volltextzugriff (PDF)

DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer

Vaccine, 2013-08, Vol.31 (37), p.3843-3848

2013

Volltextzugriff (PDF)

All trans-retinoic acid abrogates the pro-tumorigenic phenotype of prostate cancer tumor-associated macrophages

International immunopharmacology, 2014-11, Vol.23 (1), p.8-13

2014

Volltextzugriff (PDF)

Enhancement of Cellular Immune Response to a Prostate Cancer DNA Vaccine by Intradermal Electroporation

Molecular therapy, 2006-02, Vol.13 (2), p.320-327

2006

Volltextzugriff (PDF)

Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages

Cancer Immunology, Immunotherapy, 2008-10, Vol.57 (10), p.1451-1459

2008

Volltextzugriff (PDF)

The epstein‐barr virus latent membrane protein‐1 (LMP1) induces interleukin‐10 production in burkitt lymphoma lines

International journal of cancer, 1994-04, Vol.57 (2), p.240-244

1994

Volltextzugriff (PDF)

Abstract 565: A novel T-cell costimulatory Humabody® VH therapeutic for PSMA-positive tumors

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.565-565

2019

Volltextzugriff (PDF)

Optimization of Skin Electroporation in Mice to Increase Tolerability of DNA Vaccine Delivery to Patients

Molecular therapy, 2009-09, Vol.17 (9), p.1637-1642

2009

Volltextzugriff (PDF)

Tumor escape mechanisms in prostate cancer

Cancer Immunology, Immunotherapy, 2007-01, Vol.56 (1), p.81-87

2007

Volltextzugriff (PDF)

Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation

Molecular therapy, 2006-02, Vol.13 (2), p.320-327

2006

Volltextzugriff (PDF)

Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma

Expert review of anticancer therapy, 2008-10, Vol.8 (10), p.1545-1557

2008

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prediction of the Optimal Dosing Regimen Using a Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer Immunotherapy

Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment

Tumor-Specific Bacteriophages Induce Tumor Destruction through Activation of Tumor-Associated Macrophages

Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma

Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma

Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells

A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma

Modular software architecture for flexible reservation mechanisms on heterogeneous resources

HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice

Distribution of Foxp3-, CD4- and CD8-positive lymphocytic cells in benign and malignant prostate tissue

Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine

Phase 1 study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody obinutuzumab (GA101) in B-cell lymphoma patients

Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors

Interference of Macrophage Migration Inhibitory Factor Expression in a Mouse Melanoma Inhibits Tumor Establishment by Up-Regulating Thrombospondin-1

Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors

DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer

All trans-retinoic acid abrogates the pro-tumorigenic phenotype of prostate cancer tumor-associated macrophages

Enhancement of Cellular Immune Response to a Prostate Cancer DNA Vaccine by Intradermal Electroporation

Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages

The epstein‐barr virus latent membrane protein‐1 (LMP1) induces interleukin‐10 production in burkitt lymphoma lines

Abstract 565: A novel T-cell costimulatory Humabody® VH therapeutic for PSMA-positive tumors

Optimization of Skin Electroporation in Mice to Increase Tolerability of DNA Vaccine Delivery to Patients

Tumor escape mechanisms in prostate cancer

Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation

Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma

Suchergebnisse filtern